Paola Storti

University of Parma — Italy

Medicine · Health Sciences

24h-index2.0kcitations116works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(91), Peptidase Inhibition and Analysis(32), Bone health and treatments(21), Protein Degradation and Inhibitors(15), Immunotherapy and Immune Responses(11)

Publications116 total

Undetectable Minimal Residual Disease in Multiple Myeloma: Bridging the Gap Between Clinical Trials and Real-life Application
Clinical Lymphoma Myeloma & Leukemia·2025
B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape
Journal of Hematology & Oncology·2025· 2 citedOpen Access
Altered osteoblast populations dynamics underlie myeloma progression from precursors diseases in bone microenvironment
Blood·2025Open Access
High glutamate levels in the bone marrow of multiple myeloma patients promote osteoclast formation: a novel target for osteolytic bone disease
Leukemia·2025· 2 citedOpen Access
Deciphering the bone marrow microenvironment’s role in multiple myeloma immunotherapy resistance
Frontiers in Immunology·2025· 3 citedOpen Access
Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients
Frontiers in Immunology·2025Open Access
Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects
Frontiers in Immunology·2025· 8 citedOpen Access
Single Cell Transcriptomics on Bone Marrow Biopsies Unveils Peculiar Bone Microenvironment Cell Subtypes and Highlights Alterations Correlated with High-Risk Features in Precursor Monoclonal Gammopathies and Multiple Myeloma Patients
Blood·2024
Bovine Herpes Virus Type 1 Oncolytic Therapy Elicits Direct Cytotoxic Effects and Immune Microenvironment Reshaping in Multiple Myeloma
Blood·2024
Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients
Frontiers in Immunology·2024· 6 citedOpen Access
P-269 Pygo2 Is Overexpressed in Myeloma Cells With 1q21 Amplification Being Involved in Carfilzomib Resistance
Clinical Lymphoma Myeloma & Leukemia·2024
Abstract 6848: Analysis of the bone microenvironment cells by single cell transcriptomics reveals altered features in multiple myeloma patients compared to pre-malignant monoclonal gammopathies
Cancer Research·2024
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma
Nature Communications·2024· 9 citedOpen Access
CD38 expression by plasma cells In extramedullary multiple myeloma
Haematologica·2023· 5 citedOpen Access
PYGO2-MDR1 Axis in Multiple Myeloma Patients with 1q21 Amplification As Promising Target to Overcome Carfilzomib Resistance
Blood·2023· 1 cited
P-180 PYGO2 is upregulated in multiple myeloma patients with 1q21+: a potential novel therapeutic target
Clinical Lymphoma Myeloma & Leukemia·2023
Identification of <i>PSMB4</i> and <i>PSMD4</i> as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma
Haematologica·2023· 4 citedOpen Access
S185: TARGETING DNA2 OVERCOMES METABOLIC REPROGRAMMING IN 1Q21 MULTIPLE MYELOMA
HemaSphere·2023Open Access
P830: IDENTIFICATION OF NOVEL TARGET GENES CORRELATED WITH 1Q21 AMPLIFICATION IN PATIENTS WITH SMOLDERING MYELOMA AND MULTIPLE MYELOMA
HemaSphere·2023Open Access
P58 LOW CD38 EXPRESSION BY PLASMA CELLS IN EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA PATIENTS
HemaSphere·2023· 1 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Nicola Giuliani(50), Valentina Marchica(27), Marina Bolzoni(23), Denise Toscani(22), Antonino Neri(19), Benedetta Dalla Palma(19), Luca Agnelli(16), Katia Todoerti(14), Gaetano Donofrío(14), Federica Costa(12), Simona Colla(12), Sabrina Bonomini(12), Gabriella Sammarelli(12), Rosanna Vescovini(10), Franco Aversa(10), Jessica Burroughs-Garcìa(10), Eugenia Martella(9), Fabrizio Accardi(8), Irma Airoldi(8), Cristina Mancini(8)